Detalhe da pesquisa
1.
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
Immunity
; 55(3): 527-541.e5, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35231421
2.
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Br J Cancer
; 130(6): 961-969, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272963
3.
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 28(5): 433-439, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640141
4.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
5.
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
Int J Cancer
; 151(8): 1335-1344, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603906
6.
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights.
Int J Mol Sci
; 23(14)2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35886994
7.
MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features.
Mod Pathol
; 34(3): 647-659, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32770124
8.
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma.
World J Urol
; 39(5): 1377-1385, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386948
9.
Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a review.
Future Oncol
; 17(1): 91-102, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33463373
10.
The clinical role of the TME in solid cancer.
Br J Cancer
; 120(1): 45-53, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413828
11.
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies.
Cancer Immunol Immunother
; 67(6): 981-988, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28884365
12.
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer.
BJU Int
; 121(2): 203-208, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370882
13.
How molecularly similar are primary and metastatic tissues in renal cell carcinoma? - Authors' reply.
Lancet Oncol
; 23(7): e317, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772459
14.
Optimal molecular selection to benefit from nivolumab-ipilimumab in clear-cell renal cell carcinoma.
Lancet Oncol
; 23(7): e318, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772460
15.
The role of rechallenge with targeted therapies in metastatic renal-cell carcinoma.
Curr Opin Urol
; 25(5): 402-10, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26148068
16.
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.
BJU Int
; 114(1): 81-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24215209
17.
Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.
Eur Heart J
; 39(38): 3553, 2018 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30107497
18.
Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
Oncoimmunology
; 13(1): 2328433, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38487624
19.
[Treatment of metastatic prostate cancer: what recent progress?] / Traitements des cancers de la prostate métastatiques : quelles avancées récentes ?
Rev Prat
; 68(7): 707-712, 2018 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-30869315
20.
[Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies]. / Tumeurs de Bellini et carcinomes médullaires rénaux à l'ère des nouvelles thérapies.
Bull Cancer
; 110(4): 450-462, 2023 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-36906403